Provincial EPilEPsy Monitoring Unit (EMU) gUidElinEs for ontario
... multidisciplinary team of health professionals and ensure day-to-day functioning of the EMU according to provincial guidelines. The Medical Director is responsible for the quality of care delivered in the EMU beds ensuring evidence-based care. Responsibilities: • Process of admission (which include ...
... multidisciplinary team of health professionals and ensure day-to-day functioning of the EMU according to provincial guidelines. The Medical Director is responsible for the quality of care delivered in the EMU beds ensuring evidence-based care. Responsibilities: • Process of admission (which include ...
COTELLIC Product Monograph
... Elevation of serum CPK of more than 10 times the baseline value with a concurrent increase in serum creatinine of 1.5 times or greater compared to baseline occurred in 2.8% of patients in the COTELLIC plus vemurafenib arm and in 0.4% of patients in the placebo plus vemurafenib arm. One event of rhab ...
... Elevation of serum CPK of more than 10 times the baseline value with a concurrent increase in serum creatinine of 1.5 times or greater compared to baseline occurred in 2.8% of patients in the COTELLIC plus vemurafenib arm and in 0.4% of patients in the placebo plus vemurafenib arm. One event of rhab ...
Metformin and Cancer: Mounting Evidence Against
... the French lilac, has become the preferred first-line therapy for the treatment of type 2 diabetes (1). This drug is inexpensive, has an excellent safety profile, and can be safely combined with other antidiabetes agents (2). As a result, it has become the most widely prescribed antidiabetes drug worl ...
... the French lilac, has become the preferred first-line therapy for the treatment of type 2 diabetes (1). This drug is inexpensive, has an excellent safety profile, and can be safely combined with other antidiabetes agents (2). As a result, it has become the most widely prescribed antidiabetes drug worl ...
headache-curriculum
... ●Patients with atypical headache features or headaches that do not fulfill the strict definition of migraine or other primary headache disorder (or have some additional risk factor, such as immune deficiency) Patients with sudden severe headache also need neuroimaging because of the suspicion of sub ...
... ●Patients with atypical headache features or headaches that do not fulfill the strict definition of migraine or other primary headache disorder (or have some additional risk factor, such as immune deficiency) Patients with sudden severe headache also need neuroimaging because of the suspicion of sub ...
Non-invasive Ventilation Guidelines for Adult Patients with Acute
... whole or part for study or training purposes subject to the inclusion of an acknowledgment of the source. It may not be reproduced for commercial usage or sale. Reproduction for purposes other than those indicated above, requires written permission from the Agency for Clinical Innovation. © Agency f ...
... whole or part for study or training purposes subject to the inclusion of an acknowledgment of the source. It may not be reproduced for commercial usage or sale. Reproduction for purposes other than those indicated above, requires written permission from the Agency for Clinical Innovation. © Agency f ...
• AMLOR*
... found in breast milk are low, and no undesirable effects were notified on the basis of isolated cases. As a precaution mesure, it is advisable to avoid if possible, the administration of this medicine to the breast-feeding woman. 4.7 Effects on ability to drive and use machines: At the beginning of ...
... found in breast milk are low, and no undesirable effects were notified on the basis of isolated cases. As a precaution mesure, it is advisable to avoid if possible, the administration of this medicine to the breast-feeding woman. 4.7 Effects on ability to drive and use machines: At the beginning of ...
Myfortic? 180/360 mg
... Note: Renal transplant patients were treated with 1,440 mg Myfortic daily up to one year. A similar profile was seen in the de novo and maintenance transplant population although the incidence tended to be lower in the maintenance patients. Listing of adverse drug reactions from post-marketing exper ...
... Note: Renal transplant patients were treated with 1,440 mg Myfortic daily up to one year. A similar profile was seen in the de novo and maintenance transplant population although the incidence tended to be lower in the maintenance patients. Listing of adverse drug reactions from post-marketing exper ...
Prescribing Information
... observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. In all controlled and uncontrolled trials across various patient populations, more than 2,300 patients have received HORIZANT or ...
... observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. In all controlled and uncontrolled trials across various patient populations, more than 2,300 patients have received HORIZANT or ...
Policy Statement on Lumbar Spinal Fusion Surgery
... which either were not present at the time of the original operation or have worsened from their initial state an amount that is clinically substantial. c. The patient presents with clinically meaningful pain or neurological symptoms, which have been unresponsive to a minimum of 3 consecutive months ...
... which either were not present at the time of the original operation or have worsened from their initial state an amount that is clinically substantial. c. The patient presents with clinically meaningful pain or neurological symptoms, which have been unresponsive to a minimum of 3 consecutive months ...
Prescribing Information
... few cases of hepatic toxicity have been reported in adult patients receiving a rilpivirine containing regimen who had no pre-existing hepatic disease or other identifiable risk factors. Appropriate laboratory testing prior to initiating therapy and monitoring for hepatotoxicity during therapy with E ...
... few cases of hepatic toxicity have been reported in adult patients receiving a rilpivirine containing regimen who had no pre-existing hepatic disease or other identifiable risk factors. Appropriate laboratory testing prior to initiating therapy and monitoring for hepatotoxicity during therapy with E ...
PRODUCT MONOGRAPH PrSALAZOPYRIN® Sulfasalazine tablets
... About 20% of SALAZOPYRIN (sulfasalazine) is absorbed in the small intestine after oral administration. A small percentage of the absorbed sulfasalazine is excreted in the urine and the rest via the bile into the small intestine (enterohepatic circulation). This portion together with the unabsorbed s ...
... About 20% of SALAZOPYRIN (sulfasalazine) is absorbed in the small intestine after oral administration. A small percentage of the absorbed sulfasalazine is excreted in the urine and the rest via the bile into the small intestine (enterohepatic circulation). This portion together with the unabsorbed s ...
Community-Based Care Center Toolkit
... across the country. These best practices, along with input from subject matter experts in public health emergency planning, may serve as resources for any county or local planning initiative developing government-authorized Community-Based Care Centers (CBCCs) during a pandemic or other public healt ...
... across the country. These best practices, along with input from subject matter experts in public health emergency planning, may serve as resources for any county or local planning initiative developing government-authorized Community-Based Care Centers (CBCCs) during a pandemic or other public healt ...
What do patients and carers need in health apps
... innovation ecosystem to include a fresh generation of entrepreneurs and promote the cross-pollination of ideas and technology collaboration for improved healthcare delivery and outcomes in Europe. Every year the conference reconvenes over 500 movers and shakers including entrepreneurs and start-ups, ...
... innovation ecosystem to include a fresh generation of entrepreneurs and promote the cross-pollination of ideas and technology collaboration for improved healthcare delivery and outcomes in Europe. Every year the conference reconvenes over 500 movers and shakers including entrepreneurs and start-ups, ...
Diovan Prescribing Information
... appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the ...
... appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the ...
How People Cope with Poor HCI Design in Computer
... Three kinds of investigations were carried out. Nurses were interviewed about how they used the device and about their experiences with how patients/operators used the device. The investigators conducted “bench” tests of the device that explored how it behaved, how the displays represented those sta ...
... Three kinds of investigations were carried out. Nurses were interviewed about how they used the device and about their experiences with how patients/operators used the device. The investigators conducted “bench” tests of the device that explored how it behaved, how the displays represented those sta ...
Asthma and Pregnancy - Family Medicine Resident Presentations
... Towers, CV, Briggs GG, Rojas JA. The Use of Prostaglandin E2 in Pregnant Patients. Am Jour of Obstetrics and Gynecology 2005;190:1777-80. Williams Obstetrics: 22nd edition. F. Gary Cunningham, Kenneth L. Leveno, Steven L. Bloom, John C. Hauth, Larry C. Gilstrap III, Katharine D. Wenstrom. Chapters: ...
... Towers, CV, Briggs GG, Rojas JA. The Use of Prostaglandin E2 in Pregnant Patients. Am Jour of Obstetrics and Gynecology 2005;190:1777-80. Williams Obstetrics: 22nd edition. F. Gary Cunningham, Kenneth L. Leveno, Steven L. Bloom, John C. Hauth, Larry C. Gilstrap III, Katharine D. Wenstrom. Chapters: ...
Effects of the Selective Progesterone Receptor Modulator Asoprisnil
... Introduction: Asoprisnil, a novel orally active selective progesterone receptor modulator, is being studied for the management of symptomatic uterine leiomyomata. The exact mechanism of action is not yet discerned. The primary objectives of this double-blind, randomized, placebo-controlled study inc ...
... Introduction: Asoprisnil, a novel orally active selective progesterone receptor modulator, is being studied for the management of symptomatic uterine leiomyomata. The exact mechanism of action is not yet discerned. The primary objectives of this double-blind, randomized, placebo-controlled study inc ...
What are Isolation Precautions? - Vanderbilt University Medical Center
... About 30% of the US population have “staph” bacteria that normally live on the skin and in nasal passages without causing harm (colonized) Common infections caused by MRSA include skin abscesses, boils, and impetigo More serious infections that may develop include deep soft tissue abscess, blood str ...
... About 30% of the US population have “staph” bacteria that normally live on the skin and in nasal passages without causing harm (colonized) Common infections caused by MRSA include skin abscesses, boils, and impetigo More serious infections that may develop include deep soft tissue abscess, blood str ...
Full Prescribing Information
... -----------------------DOSAGE AND ADMINISTRATION-----------------------• To be prescribed only by health care providers knowledgeable in use of potent opioids for management of chronic pain. (2.1) • Use the lowest effective dosage for the shortest duration consistent with individual patient trea ...
... -----------------------DOSAGE AND ADMINISTRATION-----------------------• To be prescribed only by health care providers knowledgeable in use of potent opioids for management of chronic pain. (2.1) • Use the lowest effective dosage for the shortest duration consistent with individual patient trea ...
Is it safe to use inhaled corticosteroids in pregnancy?
... Despite research supporting the use of ICSs during pregnancy, scepticism still exists among patients and their caregivers.24 It has been estimated that only 15% of those with asthma have good adherence, and 56% have poor adherence.25 In fact, it appears that 23% to 36% of women discontinue ICS use i ...
... Despite research supporting the use of ICSs during pregnancy, scepticism still exists among patients and their caregivers.24 It has been estimated that only 15% of those with asthma have good adherence, and 56% have poor adherence.25 In fact, it appears that 23% to 36% of women discontinue ICS use i ...
Risk for Clinical Thromboembolism Associated with Conversion to
... that exist at the time of presentation would probably also exist at the time of conversion. Finally, it is possible that thrombi that were present in our patients (and, perhaps, visible on transesophageal echocardiography) did not embolize or caused subclinical events. The incidence of clinical embo ...
... that exist at the time of presentation would probably also exist at the time of conversion. Finally, it is possible that thrombi that were present in our patients (and, perhaps, visible on transesophageal echocardiography) did not embolize or caused subclinical events. The incidence of clinical embo ...
Rejuvenation of the Lip and Perioral Areas
... better filler exists. Silicone is a thick gel and feels extremely soft and natural when injected. It is a permanent filler and when used correctly provides excellent results. When a filler is classified as permanent, one must keep in mind that although the actual filler material may persist, aging, ...
... better filler exists. Silicone is a thick gel and feels extremely soft and natural when injected. It is a permanent filler and when used correctly provides excellent results. When a filler is classified as permanent, one must keep in mind that although the actual filler material may persist, aging, ...
Pocket Guide - Cancer Care Ontario
... environment and appropriate diagnostics. Delirium may interfere with optimal pain and symptom expression (self-reporting), assessment and management. In situations where a patient is not able to complete an assessment by self reporting, then the health professional and/or the caregiver may act a ...
... environment and appropriate diagnostics. Delirium may interfere with optimal pain and symptom expression (self-reporting), assessment and management. In situations where a patient is not able to complete an assessment by self reporting, then the health professional and/or the caregiver may act a ...